Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 8/20 | 0.50 |
| ▸ | LPL | P06858 | 7/20 | 0.50 |
| ▸ | RXRA | P19793 | 6/20 | 0.39 |
| ▸ | RXRB | P28702 | 6/20 | 0.39 |
| ▸ | RXRG | P48443 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.34 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23959679 | 0.95 | LIPG (0.46) | LIPGLPLRXRARXRBRXRG | |
| SCHEMBL23928342 | 0.95 | LIPG (0.46) | LIPGLPLRXRARXRBRXRG | |
| SCHEMBL23959699 | 0.93 | LIPG (0.43) | LIPGLPLRXRARXRBRXRG | |
| SCHEMBL23928339 | 0.89 | LIPG (0.40) | LIPGLPLRXRARXRBRXRG | |
| SCHEMBL9960809 | 0.89 | LIPG (0.63) | LIPGLPLKDM4EMAPTDGAT1 | |
| SCHEMBL22146484 | 0.89 | LIPG (0.63) | LIPGLPLKDM4EMAPTDGAT1 | |
| SCHEMBL23928334 | 0.87 | LIPG (0.41) | LIPGLPLRXRARXRBRXRG | |
| SCHEMBL29626015 | 0.87 | LIPG (0.61) | LIPGLPLKDM4EMAPTDGAT1 | |
| SCHEMBL28699948 | 0.87 | LIPG (0.61) | LIPGLPLKDM4EMAPTDGAT1 | |
| SCHEMBL9960711 | 0.86 | NPC1 (0.44) | LIPGLPLKDM4EGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260107625-A1 | LIGHT-EMITTING DEVICE | SEMICONDUCTOR ENERGY LAB (JP) | 2026-04-16 | — | — | US | disclosed |
| US-20260026183-A1 | Light-Emitting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2026-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260026183-A1 | Light-Emitting Device | GRIN2D, GSAP, LAMP2 | LIPG 986/4885LPL 443/4885RXRA 2984/4885 |
| US-20260107625-A1 | LIGHT-EMITTING DEVICE | LAMP2, GRIN2D, SLC1A2 | LIPG 673/4885LPL 789/4885RXRA 3961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.